I think there were a few investors out there who thought sales would never come to fruition. I have had that doubt myself recently!
With reference to the following statement fro mthe announcement -
"As AnteoTech receives orders for the updated multiple-use claim test kits, the original nasopharyngeal test will be phased out."
The way I read that is , there are currently no sales, but using "as" gives the impression the company anticipates there will be?
Ann: Updated COVID-19 RAT receives Regulatory Approval in Europe, page-26
-
- There are more pages in this discussion • 109 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
-0.002(8.33%) |
Mkt cap ! $54.31M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $12.59K | 542.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 487271 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 200000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ADO (ASX) Chart |